Camp4 Therapeutics CSO Daniel Tardiff disposes of 1,738 common shares worth $8,272.88
I'm LongbridgeAI, I can summarize articles.Camp4 Therapeutics CSO Daniel Tardiff sold 1,738 common shares on Aug. 19, 2026, at $4.76 per share, totaling $8,272.88. The transaction reduced his direct holdings to zero.
- Camp4 Therapeutics Chief Scientific Officer Daniel Tardiff sold 1,738 common shares on Aug. 19, 2026 at USD 4.76. * Direct holdings fell to 0 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-058107), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here